Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 6/20 | 0.51 |
| ▸ | NAMPT | P43490 | 1/20 | 0.46 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.46 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.44 |
| ▸ | VNN1 | O95497 | 3/20 | 0.42 |
| ▸ | DRD3 | P35462 | 2/20 | 0.42 |
| ▸ | DRD2 | P14416 | 1/20 | 0.42 |
| ▸ | CDK2 | P24941 | 3/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12953859 | 0.92 | GSK3B (0.53) | GSK3BNAMPTCHEK1AKR1C3DRD3 | |
| SCHEMBL13119167 | 0.92 | GSK3B (0.64) | GSK3BCDK2CCNE1 | |
| SCHEMBL14051095 | 0.86 | GSK3B (0.50) | GSK3BCHEK1VNN1CDK2CCNE1 | |
| SCHEMBL14307159 | 0.85 | GSK3B (0.52) | GSK3BCHEK1VNN1CDK2CCNE1 | |
| SCHEMBL13305284 | 0.85 | GSK3B (0.59) | GSK3BCHEK1VNN1CDK2CCNE1 | |
| SCHEMBL13304611 | 0.85 | GSK3B (0.59) | GSK3BCHEK1VNN1CDK2CCNE1 | |
| SCHEMBL13304610 | 0.85 | GSK3B (0.59) | GSK3BCHEK1VNN1CDK2CCNE1 | |
| SCHEMBL14050918 | 0.85 | GSK3B (0.55) | GSK3BNAMPTCHEK1VNN1CDK2 | |
| SCHEMBL14043165 | 0.85 | GSK3B (0.56) | GSK3BCHEK1VNN1CDK2CCNE1 | |
| SCHEMBL14301565 | 0.84 | GSK3B (0.53) | GSK3BCHEK1VNN1CDK2CCNE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1720882-B1 | PYRAZOLOPYRIMIDINE-DERIVATIVES AS CYCLIN DEPENDENT KINASE INHIBITORS | SCHERING CORP (US) | 2011-01-05 | — | — | EP | disclosed |